Most cited papers from 3D-Micromac (Germany)

3D-Micromac (Germany)

What are the most cited papers from 3D-Micromac (Germany)?

The most cited paper from 3D-Micromac (Germany) is "Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody" (Ralf Christian Bargou, Eugen Leo, Gerhard Zugmaier et al., 2008), with 1,087 citations. Next come "Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival" (921) and "Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers" (390).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 26 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody Ralf Christian Bargou, Eugen Leo, Gerhard Zugmaier et al. · Science	14 Aug 2008	1,087
2	Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival Max S. Topp et al. · Journal of Clinical Oncology Open access	17 May 2011	921
3	Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers Philip Went, Mohammad Vasei, Lukas Bubendorf et al. · British Journal of Cancer Open access	2006	390
4	Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody Torsten Dreier, Grit Lorenczewski, Christian Brandl et al. · International Journal of Cancer Open access	30 Jul 2002	359
5	Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct Patrick Hoffmann, Robert Hofmeister, Klaus Brischwein et al. · International Journal of Cancer Open access	Feb 2005	351
6	IL-27 and IFN- α Signal via Stat1 and Stat3 and Induce T-Bet and IL-12R β 2 in Naive T Cells Linda Hibbert, Stefan Pflanz, René de Waal Malefyt et al. · Journal of Interferon & Cytokine Research	Sep 2003	321
7	Combined transcriptome and genome analysis of single micrometastatic cells Christoph A. Klein, Stefan Seidl, Karina Petat‐Dutter et al. · Nature Biotechnology	Apr 2002	306
8	Ripple pattern formation on silicon surfaces by low-energy ion-beam erosion: Experiment and theory B. Ziberi, Frank Frost, Thomas Höche et al. · Physical Review B	7 Dec 2005	220
9	Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen Claudia Bluemel, Susanne Hausmann, Petra Fluhr et al. · Cancer Immunology Immunotherapy Open access	22 Mar 2010	210
10	Direct Genetic Analysis of Single Disseminated Cancer Cells for Prediction of Outcome and Therapy Selection in Esophageal Cancer Nikolas Hendrik Stoecklein, Stefan Benedikt Hosch, Martin Bezler et al. · Cancer Cell Open access	May 2008	210
11	Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer Gilbert Spizzo, Philip Went, Stephan Dirnhofer et al. · Gynecologic Oncology	7 May 2006	204
12	T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct Torsten Dreier, Patrick A. Baeuerle, Iduna Fichtner et al. · The Journal of Immunology Open access	Apr 2003	194
13	Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class Klaus Brischwein, Larissa Parr, Stefan Pflanz et al. · Journal of Immunotherapy	Nov 2007	191
14	T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Proceedings of the National Academy of Sciences Open access	28 Jun 2010	169
15	A revival of bispecific antibodies Peter Kufer, Ralf Lutterbüse, Patrick A. Baeuerle · Trends in biotechnology Review	3 Apr 2004	155
16	High-throughput generation and engineering of recombinant human antibodies Barbara Krebs, Robert Rauchenberger, Silke U. Reiffert et al. · Journal of Immunological Methods	Aug 2001	153
17	Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct Anja Löffler, Michael Gruen, Christian Wuchter et al. · Leukemia	May 2003	151
18	Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia Rupert Handgretinger, Gerhard Zugmaier, Guenter Henze et al. · Leukemia	14 Oct 2010	147
19	The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses José M.A. Moreira, Peter Scheipers, Poul Sørensen · BMC Cancer Open access	9 Nov 2003	143
20	The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct Christian Brandl, Cornelia Haas, Sandrine d’Argouges et al. · Cancer Immunology Immunotherapy Open access	19 Feb 2007	137
21	An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer Marcus Schmidt, Max Ernst Scheulen, Christian Dittrich et al. · Annals of Oncology Open access	24 Jul 2009	134
22	Expression of IL‐27 in human Th1‐associated granulomatous diseases Fréderique Larousserie, Stefan Pflanz, Aurore Coulomb L’Herminé et al. · The Journal of Pathology	19 Jan 2004	133
23	Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies Markus Münz, Alexander Murr, Majk Kvesic et al. · Cancer Cell International Open access	2 Nov 2010	123
24	T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct Bernd Schlereth, Cornelia Quadt, Torsten Dreier et al. · Cancer Immunology Immunotherapy Open access	19 Jul 2005	103
25	In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment Stefanie Naundorf, Susanne Preithner, Petra Mayer et al. · International Journal of Cancer Open access	29 May 2002	101
26	Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab Dirk Nagorsen, Ralf Christian Bargou, Dominik Rüttinger et al. · Leukemia & lymphoma/Leukemia and lymphoma	2009	101
27	Application of a hexapole collision and reaction cell in ICP-MS Part II: Analytical figures of merit and first applications Ines Feldmann, Norbert Jakubowski, Christoph Thomas et al. · Fresenius Journal of Analytical Chemistry	14 Oct 1999	98
28	Highly ordered self-organized dot patterns on Si surfaces by low-energy ion-beam erosion B. Ziberi, Frank Frost, Bernd Rauschenbach et al. · Applied Physics Letters	12 Jul 2005	88
29	A Subset of Human Dendritic Cells in the T Cell Area of Mucosa-Associated Lymphoid Tissue with a High Potential to Produce TNF-α Annegret de Baey, Ines Mende, Gustavo Bruno Baretton et al. · The Journal of Immunology Open access	May 2003	87
30	Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells Ines Herrmann, Patrick A. Baeuerle, Matthias Friedrich et al. · PLoS ONE Open access	18 Oct 2010	86
31	Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Journal of Immunotherapy	May 2009	78
32	W-Band Waveguide Bandpass Filters Fabricated by Micro Laser Sintering Milan Salek, Xiaobang Shang, Robert C. Roberts et al. · IEEE Transactions on Circuits & Systems II Express Briefs Open access	10 Apr 2018	77
33	New Aspects of Laser Microdissection in Research and Routine Renate Burgemeister · Journal of Histochemistry & Cytochemistry Open access	Mar 2005	70
34	Static-charging mitigation and contamination avoidance by selective carbon coating of TEM samples Thomas Höche, Jürgen W. Gerlach, Tino Petsch · Ultramicroscopy	7 Jul 2006	67
35	Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy Sonja Offner, Armin Hekele, Ulrike Teichmann et al. · Cancer Immunology Immunotherapy Open access	16 Oct 2004	63
36	Antitumor Activity of an EpCAM/CD3-bispecific BiTE Antibody During Long-term Treatment of Mice in the Absence of T-cell Anergy and Sustained Cytokine Release Maria Amann, Sandrine d’Argouges, Grit Lorenczewski et al. · Journal of Immunotherapy	21 May 2009	62
37	Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor α-independent mouse model Christine Plater-Zyberk, Leo A. B. Joosten, M.M. Helsen et al. · Annals of the Rheumatic Diseases	22 May 2008	60
38	Phenotype and function of human dendritic cells derived from M-DC8+ monocytes Annegret de Baey, Ines Mende, Gert Riethmüeller et al. · European Journal of Immunology Open access	Jun 2001	59
39	Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty Thomas Georg Nührenberg, Rainer Voisard, Felicitas Fahlisch et al. · The FASEB Journal	16 Nov 2004	56
40	Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer Marcus Schmidt, Dominik Rüttinger, Martin Sebastian et al. · Annals of Oncology Open access	22 Feb 2012	54
41	Live Cell Catapulting and Recultivation Monika Stich, Stefan Thalhammer, Renate Burgemeister et al. · Pathology - Research and Practice	2003	54
42	Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3 Bernd Schlereth, Petra Kleindienst, Iduna Fichtner et al. · Cancer Immunology Immunotherapy Open access	26 Sep 2005	54
43	Etching of CuInSe2 thin films—comparison of femtosecond and picosecond laser ablation David Ruthe, Klaus Zimmer, Thomas Höche · Applied Surface Science	15 May 2005	52
44	GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice Christine Plater-Zyberk, Leo A. B. Joosten, M.M. Helsen et al. · Annals of the Rheumatic Diseases Open access	5 Oct 2006	49
45	Rapamycin Effects Transcriptional Programs in Smooth Muscle Cells Controlling Proliferative and Inflammatory Properties Dietlind Zohlnhöfer, Thomas Georg Nührenberg, Franz‐Josef Neumann et al. · Molecular Pharmacology	26 Mar 2004	49
46	Industrial freeform generation of microtools by laser micro sintering Peter Regenfuß, Lars Hartwig, S. Klötzer et al. · Rapid Prototyping Journal	26 Jan 2005	44
47	EpCAM As a Target in Cancer Therapy Olivier Gires, P.A. Bäuerle · Journal of Clinical Oncology	13 Apr 2010	43
48	High Quality Half-cell Processing Using Thermal Laser Separation Stefan Eiternick, Felix Kaule, Hans‐Ulrich Zühlke et al. · Energy Procedia Conference paperOpen access	Aug 2015	43
49	High Quality RNA Retrieved from Samples Obtained by Using LMPC (Laser Microdissection and Pressure Catapulting) Technology Renate Burgemeister, Rainer Gangnus, B. G. A. ter Haar et al. · Pathology - Research and Practice	2003	40
50	Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans Maria Amann, Matthias Friedrich, Petra Lutterbuese et al. · Cancer Immunology Immunotherapy Open access	Jul 2008	40

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.